Latest News & Updates

Breaking News

  • 1 day ago

  • Vaibhavi M.

Celularity Appoints Rick Gonzalez as Chief Commercial Officer to Lead Cenplacel-L and Lifebank Commercialization
Breaking News
Novartis Submits Cosentyx for PMR Review in US, EU, and Japan After Phase III REPLENISH Data

Vaibhavi M.

Other trending news you may like to read

Celularity Appoints Rick Gonzalez as Chief Commercial Officer to Lead Cenplacel-L and Lifebank Commercialization

Celularity names Rick Gonzalez CCO to drive global commercialization of cenplacel-L and Lifebank across permissive international markets.

Vaibhavi M.

Pharma Now

Novartis Submits Cosentyx for PMR Review in US, EU, and Japan After Phase III REPLENISH Data

Novartis files Cosentyx for PMR in US, EU, and Japan after Phase III REPLENISH data showed double the sustained remission rate vs placebo.

Vaibhavi M.

Pharma Now

FDA Publishes RWE Landscape Analysis Covering Regulatory Decisions Across CDER, CBER, and CDRH Since 2011

FDA publishes RWE landscape analysis covering approvals, labeling changes, and no-action determinations across CDER, CBER, and CDRH since 2011.

Vaibhavi M.

Pharma Now

Omnix Medical Doses First Patients in Phase II Trial of Antimicrobial Compound OMN6

Omnix Medical doses first Phase II patients with OMN6, a first-in-class antimicrobial targeting drug-resistant Acinetobacter baumannii.

Vaibhavi M.

Pharma Now